Pegzilarginase in Subjects <24 Months Old With Arginase 1 Deficiency

Clinical trial NCT06582524 · COMPLETED

Trial details

NCT number: NCT06582524
Sponsor: Immedica Pharma AB
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Arginase 1 Deficiency

Start date: 2024-08-30
Primary completion: 2025-06-17
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.